Andreas Bender/Developing and applying novel data mining approaches of chemical and biological data, in drug discovery, chemical biology, and in silico toxicology/Reader at the Centre for Molecular Science Informatics of the University of Cambridge/Co-founder of Healx Ltd., for data-driven drug repurposing for rare diseases http://www.healx.io/Co-founder of PharmEnable Ltd., for accessing new chemistry for difficult targets http://www.pharmenable.com
Machine Learning and Artificial Intelligence are increasing in importance currently – due to significantly increased… Read More »DrugDiscovery.NET – AI and Machine Learning in Drug Discovery, in Practice
Andreas Bender E-Mail: andreas AT drugdiscovery DOT net Web: http://andreasbender.de/ LinkedIn: https://www.linkedin.com/in/andreas-bender-1441441/ Twitter: https://twitter.com/AndreasBenderUK UK… Read More »Contact